Investor Relations

IVVD

Quote

Short

News

Articles

Message Board

Invivyd Inc. (NASDAQ : IVVD ) News

News Releases

IVVD News Releases

July 06, 2026 07:36:08 am

SeekingAlpha

Invivyd gets notice of Pemgarda EUA termination

July 06, 2026 07:01:00 am

GlobeNewswire

Invivyd Announces Receipt of Twelve Months' Advanced Notice of Emergency Use Authorization (EUA) Termination for PEMGARDA® and Provides an Update on Next Steps with the U.S. FDA

June 29, 2026 07:00:00 am

GlobeNewswire

NovaBridge Biosciences Appoints Dr. Srishti Gupta as Chief Executive Officer

June 16, 2026 07:01:00 am

GlobeNewswire

Invivyd Announces Completion of Enrollment in Phase 3 LIBERTY Trial Evaluating VYD2311 Antibody Versus mRNA COVID-19 Vaccine

June 09, 2026 07:01:00 am

GlobeNewswire

Invivyd Announces First Participants Dosed in LIBERTY, a Phase 3 Clinical Trial to Evaluate the Safety and Tolerability of VYD2311 Antibody Versus mRNA COVID Vaccine and to Characterize the Safety and Immunology of Antibody a

June 01, 2026 07:01:00 am

GlobeNewswire

Invivyd Announces Completion of Enrollment in Upsized DECLARATION Clinical Trial, a Phase 3 Pivotal Study of VYD2311, an Investigational Antibody to Prevent COVID

May 27, 2026 07:01:00 am

GlobeNewswire

Invivyd to Participate in Upcoming Investor Events

May 14, 2026 02:47:22 pm

Motley Fool

Invivyd (IVVD) Q1 2026 Earnings Transcript

May 14, 2026 12:32:08 pm

SeekingAlpha

Invivyd outlines VYD2311 path as PEMGARDA grows 22% year-over-year while DECLARATION recruitment nears completion

May 14, 2026 12:31:03 pm

SeekingAlpha

Invivyd, Inc. (IVVD) Q1 2026 Earnings Call Transcript

	Next 10

Subscribe to Our Newsletter

Download The Market Wire News App

Link Market Wire News to Your X Account